Dendritic cells from patients with chronic myeloid leukemia: Functional and phenotypic features
- 1 May 2005
- journal article
- review article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 46 (5) , 663-670
- https://doi.org/10.1080/10428190400029825
Abstract
Dendritic cells (DCs) are professional antigen-presenting cells playing a pivotal role in the induction of humoral and cellular immune responses, and chronic myeloid leukemia-derived DCs (CML-DCs) are possible candidates for inducing anti-leukemic immunity. This review describes phenotypic and functional features of DCs derived from CML patients as compared with DCs from healthy volunteers. In short, distinct deficiencies have been reported for CML-DCs, such as reduced migration, endocytosis, phagocytosis, antigen processing, DC maturation and cytokine production. DC abnormalities of CML patients can be abrogated by proper in vitro stimulation of leukemic DCs. This underscores the importance of proper generation and maturation of CML-DCs when considering clinical vaccination protocols.Keywords
This publication has 62 references indexed in Scilit:
- Defective blood dendritic cells in chronic myeloid leukemia correlate with high plasmatic VEGF and are not normalized by imatinib mesylateLeukemia, 2004
- Imatinib mesylate impairs Flt3L-mediated dendritic cell expansion and antitumor effects in vivoBlood, 2004
- IFN-α promotes the rapid differentiation of monocytes from patients with chronic myeloid leukemia into activated dendritic cells tuned to undergo full maturation after LPS treatmentBlood, 2004
- Vaccination of chronic myeloid leukemia patients with autologous in vitro cultured leukemic dendritic cellsLeukemia, 2003
- MAP Kinases in the Immune ResponseAnnual Review of Immunology, 2002
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001
- In vitro cytokine-primed leukaemia cells induce in vivo T cell responsiveness in chronic myeloid leukaemiaBone Marrow Transplantation, 1998
- Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cellsHuman Immunology, 1997
- Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cellsNature Medicine, 1996
- The Pathophysiology of Tumor Necrosis FactorsAnnual Review of Immunology, 1992